Edwards Lifesciences (EW)

=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-08-26 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: Edwards Lifesciences Corp (EW) CIK: 0001099800 --- Reporting Owner --- Name: Chopra Daveen CIK: 0001740963 Role: Officer (CVP, TMTT, Surgical & IHFM) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-08-26 | Code: M (Exercise of derivative) Shares: +31,800 | Price: $72.68 Total Value: $2,311,224.00 Shares Owned After: 76,124 | Ownership: D (Direct) [Transaction #2] Security: Common Stock Date: 2026-08-26 | Code: S (Open market sale) Shares: -1,154 | Price: $91.76 Total Value: $105,892.66 Shares Owned After: 74,970 | Ownership: D (Direct) Footnotes: [F1] This transaction was executed in multiple trades at prices ranging from $91.660 to $91.975. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. [Transaction #3] Security: Common Stock Date: 2026-08-26 | Code: S (Open market sale) Shares: -30,646 | Price: $90.99 Total Value: $2,788,546.96 Shares Owned After: 44,324 | Ownership: D (Direct) Footnotes: [F2] This transaction was executed in multiple trades at prices ranging from $90.645 to $91.640. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. --- Derivative Transactions --- [Transaction #1] Security: Employee Stock Option (Right to Acquire) Date: 2026-08-26 | Code: M (Exercise of derivative) Shares: -31,800 | Price: $0.00 Exercise Price: $72.68 Exercisable: N/A | Expires: 2027-05-06 Shares Owned After: 0 | Ownership: D (Direct) --- Footnotes (Complete Index) --- F1: This transaction was executed in multiple trades at prices ranging from $91.660 to $91.975. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. F2: This transaction was executed in multiple trades at prices ranging from $90.645 to $91.640. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. --- Signature --- /s/ Linda J. Park, Attorney-in-Fact (2026-08-26)